Back to 
Grantham, Mayo, Van Otterloo & Co. LLC
Grantham, Mayo, Van Otterloo & Co. LLC
CORT
Showing 0 of 2 quarters
Position history for Grantham, Mayo, Van Otterloo & Co. LLC's holdings in Corcept Therapeutics Incorporated
No. Grantham, Mayo, Van Otterloo exited its CORT (Corcept Therapeutics) position in Q2 2020. Its Q1 2020 13F listed 14,900 shares worth $177,000. Grantham, Mayo, Van Otterloo first reported CORT in Q1 2020 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.